Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dharmalingam Subramaniam

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Chemical Biology & Drug Design|November 24, 2011
Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH)Pallavi Lagisetty, Dharmalingam Subramaniam, Kaustuv Sahoo, et al.
Current Colorectal Cancer Reports|January 10, 2015
Histone Demethylases in Colon CancerSantanu Paul, Satish Ramalingam, Dharmalingam Subramaniam, et al.
Chemmedchem|March 24, 2018
Halogenated Bis(methoxybenzylidene)-4-piperidone Curcuminoids with Improved Anticancer ActivityFlorian Schmitt, Dharmalingam Subramaniam, Shrikant Anant, et al.
Journal of Hematology & Oncology|January 8, 2017
Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapyPablo Angulo, Gaurav Kaushik, Dharmalingam Subramaniam, et al.
Nutrition and Cancer|December 11, 2020
Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A ReviewConnor Chestnut, Dharmalingam Subramaniam, Prasad Dandawate, et al.
American Journal of Surgery|December 3, 2014
Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathwayGaurav Kaushik, Deep Kwatra, Dharmalingam Subramaniam, et al.
Plos One|February 25, 2012
Curcumin induces cell death in esophageal cancer cells through modulating Notch signalingDharmalingam Subramaniam, Sivapriya Ponnurangam, Prabhu Ramamoorthy, et al.
Gastroenterology|May 19, 2009
Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanismSripathi M Sureban, Randal May, Satish Ramalingam, et al.
Oncotarget|March 23, 2019
Super-enhancers: novel target for pancreatic ductal adenocarcinomaChandrayee Ghosh, Santanu Paul, Prasad Dandawate, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 13, 2011
Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defectsZhiyun He, Dharmalingam Subramaniam, Satish Ramalingam, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Chemical Biology & Drug Design|November 24, 2011
Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH)Pallavi Lagisetty, Dharmalingam Subramaniam, Kaustuv Sahoo, et al.
Current Colorectal Cancer Reports|January 10, 2015
Histone Demethylases in Colon CancerSantanu Paul, Satish Ramalingam, Dharmalingam Subramaniam, et al.
Chemmedchem|March 24, 2018
Halogenated Bis(methoxybenzylidene)-4-piperidone Curcuminoids with Improved Anticancer ActivityFlorian Schmitt, Dharmalingam Subramaniam, Shrikant Anant, et al.
Journal of Hematology & Oncology|January 8, 2017
Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapyPablo Angulo, Gaurav Kaushik, Dharmalingam Subramaniam, et al.
Nutrition and Cancer|December 11, 2020
Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A ReviewConnor Chestnut, Dharmalingam Subramaniam, Prasad Dandawate, et al.
American Journal of Surgery|December 3, 2014
Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathwayGaurav Kaushik, Deep Kwatra, Dharmalingam Subramaniam, et al.
Plos One|February 25, 2012
Curcumin induces cell death in esophageal cancer cells through modulating Notch signalingDharmalingam Subramaniam, Sivapriya Ponnurangam, Prabhu Ramamoorthy, et al.
Gastroenterology|May 19, 2009
Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanismSripathi M Sureban, Randal May, Satish Ramalingam, et al.
Oncotarget|March 23, 2019
Super-enhancers: novel target for pancreatic ductal adenocarcinomaChandrayee Ghosh, Santanu Paul, Prasad Dandawate, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 13, 2011
Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defectsZhiyun He, Dharmalingam Subramaniam, Satish Ramalingam, et al.
Pageof 6